ArticleJournal of neuroinflammation2023

Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS.

Valentina Pegoretti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.